Skip to content

Paracervical Versus Intracervical Lidocaine

Paracervical Versus Intracervical Lidocaine for Suction Curettage: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00816751
Enrollment
89
Registered
2009-01-05
Start date
2007-12-31
Completion date
2008-02-29
Last updated
2019-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Induced, Pain

Keywords

Local anesthesia, Paracervical, Intracervical, Abortion, Pain, Local anesthesia for elective first trimester abortion

Brief summary

The aim of this study is to estimate the efficacy of intracervical versus paracervical block on pain experienced during first trimester suction curettage without the use of preoperative cervical ripening. Because of the theoretical improved reliability of stromal block, the investigators hypothesize that intracervical block would produce lower pain scores than paracervical block at the time of cervical dilation.

Interventions

The paracervical block was administered using 20 ml of buffered lidocaine and a 5/8 inch, 25-gauge needle. A small amount was injected at the tenaculum site, and the remainder equally distributed around the cervicovaginal junction at 3, 5, 7, and 9 o'clock. The depth was standardized at 5/8 inch by inserting the needle to the hub.

PROCEDUREIntracervical

The intracervical block was administered using 20 ml of buffered lidocaine and a 1-1/2 inch, 20 gauge needle in order to overcome the increased resistance to injection caused by the cervical stroma. A small amount was injected at the tenaculum site, and the remainder into the cervical stroma at 12, 3, 6, and 9 o'clock, at a depth of 1-1/2 inch by inserting the needle to the hub.

DRUGBuffered Lidocaine, vasopressin, sodium bicarbonate

The buffered lidocaine preparation for both block techniques consisted of 50 mL of 1% lidocaine, 5 units of vasopressin, and 5 mL 8% sodium bicarbonate.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women presenting for elective first trimester abortion

Exclusion criteria

* Gestation over 12 weeks by ultrasound * Weight less than 98 pounds * Known allergy to lidocaine * Known nonviable pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Pain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)at completion of procedureVAS on a scale of 1 to 10 with 1 being lowest pain and 10 highest amount of pain

Secondary

MeasureTime frame
Gestational Age at Time of ProcedureAt the time of the procedure

Countries

United States

Participant flow

Participants by arm

ArmCount
Paracervical Block
All patients who met inclusion criteria were approached for the study. Exclusion criteria included gestational age greater than 12 weeks, patient age less than 18, patient weight less than 44 kg, patient allergy to any component of the local anesthetic, patient need for general anesthesia, inability to understand the consent form, nonviable pregnancy, current incarceration.
45
Intracervical Block
All patients who met inclusion criteria were approached for the study. Exclusion criteria included gestational age greater than 12 weeks, patient age less than 18, patient weight less than 44 kg, patient allergy to any component of the local anesthetic, patient need for general anesthesia, inability to understand the consent form, nonviable pregnancy, current incarceration.
44
Total89

Baseline characteristics

CharacteristicParacervical BlockIntracervical BlockTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
45 Participants44 Participants89 Participants
Sex: Female, Male
Female
45 Participants44 Participants89 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 450 / 44
other
Total, other adverse events
0 / 450 / 44
serious
Total, serious adverse events
0 / 450 / 44

Outcome results

Primary

Pain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)

VAS on a scale of 1 to 10 with 1 being lowest pain and 10 highest amount of pain

Time frame: at completion of procedure

ArmMeasureValue (MEAN)Dispersion
Paracervical BlockPain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)4.25 units on a scaleStandard Deviation 0.6
Intracervical BlockPain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)3.97 units on a scaleStandard Deviation 0.5
Secondary

Gestational Age at Time of Procedure

Time frame: At the time of the procedure

ArmMeasureValue (MEAN)Dispersion
Paracervical BlockGestational Age at Time of Procedure51 DaysStandard Deviation 11
Intracervical BlockGestational Age at Time of Procedure54 DaysStandard Deviation 9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026